Novavax Inc. (NVAX)
NASDAQ: NVAX
· Real-Time Price · USD
8.48
-0.43 (-4.83%)
At close: Oct 16, 2025, 3:59 PM
8.83
4.13%
After-hours: Oct 16, 2025, 07:59 PM EDT
-4.83% (1D)
Bid | 8.33 |
Market Cap | 1.38B |
Revenue (ttm) | 1.08B |
Net Income (ttm) | 422.82M |
EPS (ttm) | 2.22 |
PE Ratio (ttm) | 3.82 |
Forward PE | 111.12 |
Analyst | Sell |
Dividends | n/a |
Ask | 9.19 |
Volume | 5,109,738 |
Avg. Volume (20D) | 6,366,534 |
Open | 8.93 |
Previous Close | 8.91 |
Day's Range | 8.46 - 9.10 |
52-Week Range | 5.01 - 11.55 |
Beta | 2.75 |
Ex-Dividend Date | n/a |
About NVAX
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol NVAX
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for NVAX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsNovavax Inc. is scheduled to release its earnings on
Nov 11, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
2 days ago
+3.13%
Novavax shares are trading higher after Shah Capit...
Unlock content with
Pro Subscription
1 month ago
-4.08%
Shares of vaccine companies are trading lower following a Daily Beast report suggesting that President Trump and Health and Human Services Robert F. Kennedy, Jr. will ban Covid-19 vaccines "within months." Also, a report suggested that a Covid-19 vaccine skeptic will lead the Covid-19 immunization task force.